Bristol Myers Squibb to Participate in the Bernstein 41st Annual Strategic Decisions ConferenceBusiness Wire • 05/21/25
Amgen vs Bristol Myers: Which Biotech Giant Has Better Prospects?Zacks Investment Research • 05/19/25
Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%Business Wire • 05/16/25
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - YetSeeking Alpha • 05/12/25
Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning labelReuters • 05/10/25
Dividend Harvesting Portfolio Week 218: $21,800 Allocated, $2,195.04 In Projected DividendsSeeking Alpha • 05/08/25
Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy OfficerBusiness Wire • 05/06/25
First-Quarter GDP Halfway to Recession: Move to These Safe High-Yield Dividend Stocks Now24/7 Wall Street • 05/01/25
BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?Zacks Investment Research • 04/28/25
Exclusive: US pharma tariffs would raise US drug costs by $51 bln annually, report findsReuters • 04/25/25